Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination therapy with mocetinostat, an oral, spectrum-selective histone deacetylase (HDAC) inhibitor, and 5-azaciditine: Indication of clinical activity in MDS
    Meeting Abstract

    Garcia Manero, G.; Selina, L.; Virginia, K.; Maureen, C.; Besa, E. C.; Rossetti, J. M.; Chao, R.; Humphrey, R.; Silverman, L. R.
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Prognostic impact of MLL5 transcript levels on outcome of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: An International Consortium on Acute Promyelocytic Leukemia study
    Meeting Abstract

    Lucena-Araujo, A. R.; Kim, H. T.; Jacomo, R.; Melo, R. A.; Bittencourt, R.; Pasquini, R.; Pagnano, K. B.; Fagundes, E.; Chauffaille, M. d. L. L. F; Lima, A. S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations in hematologic malignancies by a clinical next generation sequencing-based assay
    Meeting Abstract

    Lipson, D.; Nahas, M. K.; Otto, G. A.; Yelensky, R.; Abdel-Wahab, O.; Wang, K.; He, J.; Intlekofer, A. M.; Rampal, R. K.; Brennan, T. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Patient derived xenograft (PDX) models faithfully recapitulate the genetic composition of primary AML
    Meeting Abstract

    Krivtsov, A. V.; Xujun, W.; Farnoud, N. R.; Hadler, M.; Knapp, K. M.; Stein, E. M.; Tallman, M. S.; Donahue, A. L.; Lipson, D.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 ((225)Ac)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Cicic, D.; Scheinberg, D. A.
    Blood (2013)

    Fulltext@MSK | Save
  • Chronic myeloid leukemia after adjuvant treatment for breast cancer: Is it therapy related?
    Meeting Abstract

    Kishtagari, A.; Bowman, I. A.; Tallman, M. S.; Douer, D.; Berman, E.; Maslak, P. G.; Brentjens, R. J.; Stein, E. M.
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Autologous hematopoietic cell transplantation (HCT) is superior to allogeneic transplantation for acute promyelocytic leukemia in second complete remission (CR2)
    Meeting Abstract

    Holter-Chakrabarty, J. L.; Rubinger, M.; Grigg, A.; Szer, J.; Selby, G.; Rowe, J. M.; Le Rademacher, J.; Wang, H. L.; Weisdorf, D. J.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save
  • miR-29a maintains hematopoietic stem cell self-renewal and is required for myeloid leukemogenesis
    Meeting Abstract

    Hu, W.; Dooley, J.; Chung, S. S.; Yalcin, S.; Shin, Y. S.; De Strooper, B.; Liston, A.; Park, C. Y.
    Blood (2013)

    Fulltext@MSK | Save